Other terms
UDL Brand of Triazolam,Triazolam UDL Brand,Roxane Brand of Triazolam,Triazolam Roxane Brand,Schein Brand of Triazolam,Triazolam Schein Brand,Greenstone Brand of Triazolam,Triazolam Greenstone Brand,Par Brand of Triazolam,Triazolam Par Brand,U-33,030,U 33,030,U33,030,Halcion,Pharmacia Spain Brand of Triazolam,Pharmacia Brand of Triazolam,Trilam,Gerard Brand of Triazolam,Apo-Triazo,Apo Triazo,Apotex Brand of Triazolam,Gen-Triazolam,Gen Triazolam,Genpharm Brand of Triazolam
Description
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Pervious tree
Next tree
Other locations in tree
Legal notice
The U.S. National Library of Medicine is the creator, maintainer, and provider of the data above.
The version of the data is 2010 MeSH. Last reviewed April 26, 2010. No modification has been made in the content of the file.
Neither the United States Government, nor any of its agencies, contractors, subcontractors or employees makes any warranties, expressed or implied, with respect to data contained in the database, and, furthermore, assumes no legal liability for any party's use, or the results of such use, of any part of the database.
You will not assert any proprietary rights to any portion of the database, or represent the database or any part thereof to anyone as other than a United States Government database.
The MeSH data carry an international copyright outside the United States, its Territories or Possessions. These terms and conditions are in effect as long as the user retains any of the MeSH data obtained from this site.